eye rot semaglutide linked to higher risk of vision problems, FDA data analysis shows Wegovy Vision Loss Lawsuit [2026

With advancements in weight-loss treatments, options like glucagon-like peptide-1 (GLP-1) receptor agonists and bariatric surgery are helping individuals achieve their goals.

We focus on protein preservation, fiber optimization, and micronutrient adequacy to support your long-term success and health

Learn about drug interactions with immunosuppressants, monitoring requirements, NHS guidance, and emerging clinical evidence for kidney, liver, and heart transplant recipients.

Our commitment to safe, responsible GLP-1 care

Kentucky considers expanding Medicaid access to GLP-1 weight-loss drugs as federal discounts and rising costs shape the next state budget debate.

These actions have been clinically exploited by the development of amylin and GLP-1 hormone analogs now used for treatment of diabetes and obesity